Exousia Bio reported net income of -$0.02M for the quarter ended Feb 2026. This income statement covers 16 quarters of results from May 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | May2022 | Aug2022 | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||
| Revenue | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||||||
| Cost of RevenueCost of Rev | 0.01M | 0.00M | 0.01M | 0.06M | 0.06M | |||||||||||
| Gross Profit | 0.00M | 0.00M | -0.01M | 0.00M | -0.01M | -0.06M | -0.06M | |||||||||
| Operating items | ||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 0.00M | |||||||||||||||
| Selling, General & AdministrativeSG&A | 0.01M | 0.01M | 0.01M | 0.03M | 0.01M | 0.01M | 0.01M | -228.00 | 0.01M | 0.01M | 0.01M | 0.02M | ||||
| Other Operating ExpensesOther Opex | -0.00M | 0.00M | 0.03M | 0.17M | 0.17M | |||||||||||
| Operating ExpensesOpex | 0.01M | 0.01M | 0.01M | 0.03M | 0.01M | 0.01M | 0.01M | -228.00 | 0.01M | 0.01M | 0.01M | 0.02M | 0.03M | 0.17M | 0.17M | |
| Operating IncomeOp. Inc | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.01M | -0.01M | -0.01M | -0.00M | 0.01M | 0.01M | -0.03M | -0.03M | -0.24M | -0.24M | |
| EBIT | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.01M | -0.01M | -0.01M | -0.00M | 0.01M | 0.01M | -0.03M | -0.03M | -0.24M | -0.24M | |
| Non-operating items | ||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 431.00 | |||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 436.00 | 431.00 | 0.09M | 0.09M | -802.00 | 0.22M | 0.22M | |||||||||
| Net income details | ||||||||||||||||
| EBT | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M | 0.08M | 0.08M | -0.03M | -0.03M | -0.02M | -0.02M | |
| Tax ProvisionsTaxes | 0.02M | |||||||||||||||
| Profit After TaxPAT | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M | 0.08M | 0.08M | -0.03M | -0.03M | -0.02M | -0.02M | |
| Income from Continuing OperationsIncome (Continuing) | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M | 0.08M | 0.08M | -0.05M | -0.03M | -0.02M | -0.02M | |
| Consolidated Net IncomeConsol Net Inc. | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M | 0.08M | 0.08M | -0.05M | -0.03M | -0.02M | -0.02M | |
| Income towards Parent CompanyParent Net Inc | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M | 0.08M | 0.08M | -0.05M | -0.03M | -0.02M | -0.02M | |
| Net Income towards Common StockholdersNet Income | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.00M | -0.00M | -0.01M | -0.00M | 0.08M | 0.08M | -0.05M | -0.03M | -0.02M | -0.02M | |
| Additional items | ||||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | |
| Shares Outstanding | 1.63M | 5.00M | 5.00M | 5.30M | 5.69M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 16.76M | 16.76M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.63M | 5.00M | 5.00M | 5.30M | 5.69M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 16.76M | 16.76M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.63M | 5.00M | 5.00M | 5.30M | 5.00M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 7.78M | 16.76M | 16.76M |
| EBITDA | -0.01M | -0.01M | -0.01M | -0.03M | -0.01M | -0.01M | -0.01M | -0.01M | -666.00 | 0.01M | 0.01M | -0.03M | -0.03M | -0.24M | -0.24M | |
| Interest ExpensesInt Expense | 0.00M | |||||||||||||||
| Tax Rate | -59.68% |